Benitec Biopharma (BNTC) Payables: 2019-2025
Historic Payables for Benitec Biopharma (BNTC) over the last 5 years, with Mar 2025 value amounting to $6.3 million.
- Benitec Biopharma's Payables rose 137.98% to $6.3 million in Q1 2025 from the same period last year, while for Mar 2025 it was $16.7 million, marking a year-over-year increase of 14.33%. This contributed to the annual value of $4.2 million for FY2024, which is 28.91% up from last year.
- Per Benitec Biopharma's latest filing, its Payables stood at $6.3 million for Q1 2025, which was up 158.96% from $2.4 million recorded in Q4 2024.
- In the past 5 years, Benitec Biopharma's Payables ranged from a high of $6.3 million in Q1 2025 and a low of $880,000 during Q2 2021.
- In the last 3 years, Benitec Biopharma's Payables had a median value of $3.8 million in 2023 and averaged $3.7 million.
- Per our database at Business Quant, Benitec Biopharma's Payables surged by 448.17% in 2021 and then slumped by 51.08% in 2024.
- Quarterly analysis of 5 years shows Benitec Biopharma's Payables stood at $1.9 million in 2021, then decreased by 5.96% to $1.8 million in 2022, then spiked by 169.78% to $4.9 million in 2023, then tumbled by 51.08% to $2.4 million in 2024, then soared by 137.98% to $6.3 million in 2025.
- Its Payables was $6.3 million in Q1 2025, compared to $2.4 million in Q4 2024 and $3.8 million in Q3 2024.